Citations

Showing 10 of 108104 citations.

Do histopathological features correlate with systemic manifestations in dermatomyositis? Analysis of 42 skin biopsy specimens from 22 patients
Shakshouk, Hadir , Deschaine, Maria , Wetter, David A. , Drage, Lisa A., Ernste, Floranne C. , Gibson, Lawrence E. , Lehman, Julia S. , Deschaine, Maria A , Lehman, Julia S , Shakshouk, H

Mayo Clinic

Journal of Cutaneous Pathology | January 26, 2022 | Volume: 49 | Issue: 5 | Pages: 442-447

10.1111/cup.14203 | PMID 35080246 Get It

AbstractBackgroundUnderstanding whether specific histopathologic features on skin biopsy are predictive of systemic associations in dermatomyositis (DM) would be useful to guide clinical screening.MethodsThrough retrospective medical record search, clinical and laboratory findings of patients with DM were documented. Existing skin biopsy slides were re‐reviewed blindly.ResultsOf all biopsy specimens (n = 42), the most frequent histopathological finding was vacuolar interface dermatitis (95%). Other features included perivascular lymphocytic infiltrate (71%), increased dermal mucin (40%), vessel wall thickening (12%), follicular plugging (9.5%), and dermal sclerosis (7%). Neutrophilic infiltrate was observed in three biopsies from a patient with adalimumab‐associated DM. Vasculitis was not observed. There was no statistically significant difference in the presence of any histopathological feature and that of various systemic manifestations (i.e., myopathy, interstitial lung disease [ILD] and malignancy). However, we observed that dense lichenoid infiltrate rather than pauci‐inflammatory changes correlated with severe itching (p < 0.001). Patients with MDA‐5 antibodies were significantly more likely to have vasculopathy than those without (p = 0.029*).ConclusionsNo dermatopathologic feature was reliably predictive of myopathy, ILD, or malignancy. This finding implies that, regardless of histopathologic findings, patients should be screened for associated conditions as clinically indicated.
Preoperative Stereotactic Radiosurgery for Glioblastoma
Lehrer, Eric J. , Sindhu, Kunal K. , Estrada, Rachel Sarabia, Borst, Gerben R. , Sheehan, Jason P. , Quiñones‐Hinojosa, Alfredo , Sindhu, Kunal K , Borst, Gerben R , Ruiz-García, Henry , Nehlsen, Anthony D. , Trifiletti, Daniel M.

Mayo Clinic

Biology | January 26, 2022 | Volume: 11 | Issue: 2 | Pages: 194

10.3390/biology11020194 | PMID 35205059 Get It

Glioblastoma is a devastating primary brain tumor with a median overall survival of approximately 15 months despite the use of optimal modern therapy. While GBM has been studied for decades, modern therapies have allowed for a reduction in treatment-related toxicities, while the prognosis has largely been unchanged. Adjuvant stereotactic radiosurgery (SRS) was previously studied in GBM; however, the results were disappointing. SRS is a highly conformal radiation technique that permits the delivery of high doses of ionizing radiation in 1–5 sessions while largely sparing surrounding healthy tissues. Furthermore, studies have shown that the delivery of ablative doses of ionizing radiation within the central nervous system is associated with enhanced anti-tumor immunity. While SRS is commonly used in the definitive and adjuvant settings for other CNS malignancies, its role in the preoperative setting has become a topic of great interest due to the potential for reduced treatment volumes due to the treatment of an intact tumor, and a lower risk of nodular leptomeningeal disease and radiation necrosis. While early reports of SRS in the adjuvant setting for glioblastoma were disappointing, its role in the preoperative setting and its impact on the anti-tumor adaptive immune response is largely unknown. In this review, we provide an overview of GBM, discuss the potential role of preoperative SRS, and discuss the possible immunogenic effects of this therapy.
3-Aminophthalic acid, a new cereblon ligand for targeted protein degradation by O’PROTAC
Yan, Yuqian , Shao, Jingwei , Ding, Donglin , Pan, Yunqian , Tran, Phuc , Li, Hongyu , Huang, Haojie , Huang, Rui , Yan, Wei , Wang, Zhenyu

Mayo Clinic

Chemical Communications | January 26, 2022 | Volume: 58 | Issue: 14 | Pages: 2383-2386

10.1039/d1cc06525d | PMID 35080528 Get It

In this study, we discovered 3-aminophthalic acid as a new ligand of cereblon (CRBN) E3 ubiquitin ligase and developed a phthalic acid-based O’PROTAC for ERG destruction, expanding the pool of ligands for development of PROTACs, especially O’PROTACs.
Crohn's Disease in a Patient With Fibrodysplasia Ossificans Progressiva
Havlichek, Daniel , Pignolo, Robert J. , Kane, Sunanda V. , Guerrero Vinsard, Daniela , Vinsard, Daniela Guerrero

Mayo Clinic

ACG Case Reports Journal | January 26, 2022 | Volume: 9 | Issue: 1 | Pages: e00737

10.14309/crj.0000000000000737 | PMID 35097150 Get It

ABSTRACT Fibrodysplasia ossificans progressiva (FOP) is a rare disease characterized by inflammatory flares of soft tissues, leading to heterotopic ossification and significant cumulative morbidity and early mortality. FOP minor trauma, including intramuscular medication administration, can induce ossification and should be avoided. We present a case of known FOP in a patient who presented with fevers of unknown origin and was found to have biopsy-proven ileal Crohn's disease. Crohn's disease management was complicated by concerns that intramuscular therapies would induce ossification, and oral monotherapy with methotrexate was initiated with excellent results.
Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort
Hirano, Ikuo , King, Eileen, Sun, Qin , Chehade, Mirna , Abonia, J. Pablo , Bonis, Peter A, Capocelli, Kelly E., Dellon, Evan S. , Gonsalves, Nirmala , Gupta, Sandeep K. , Leung, John , Katzka, David A. , Menard‐Katcher, Paul , Khoury, Paneez , Shoda, Tetsuo, Rudman-Spergel, Amanda K., Spergel, Jonathan A., Rothenberg, Marc E., Aceves, Seema S. , Furuta, Glenn T. , investigators, CEGIR, Katzka, David, Collins, Margaret H. , Falk, Gary W. , Klion, Amy D. , Mukkada, Vincent A. , Peterson, Kathryn A. , Shoda, Tetsuo , Spergel, Jonathan A., Yang, Guang‐Yu , investigators, CEGIR

Mayo Clinic

American Journal of Gastroenterology | January 26, 2022 | Volume: 117 | Issue: 3 | Pages: 413-423

10.14309/ajg.0000000000001625 | PMID 35080202 Get It

INTRODUCTION: Eosinophilic gastritis (EG) is a chronic inflammatory disease of the stomach characterized by eosinophil-predominant gastric mucosal inflammation and gastrointestinal symptoms. The aim of this study was to prospectively evaluate endoscopic features in a large series of children and adults with EG to better understand the endoscopic manifestations and develop a standardized instrument for investigations. METHODS: Data were prospectively collected as part of the Consortium for Eosinophilic Gastrointestinal Disease Researchers, a national collaborative network. Endoscopic features were prospectively recorded using a system specifically developed for EG, the EG Endoscopic Reference System (EG-REFS). Correlations were made between EG-REFS and clinical and histologic features. RESULTS: Of 98 patients with EG, 65 underwent assessments using EG-REFS. The most common findings were erythema (72%), raised lesions (49%), erosions (46%), and granularity (35%); only 8% of patients with active histology (≥30 eosinophils/high-power field) exhibited no endoscopic findings. A strong correlation between EG-REFS scores and physician global assessment of endoscopy severity was demonstrated (Spearman r = 0.84, P < 0.0001). The overall score and specific components of EG-REFS were more common in the antrum than in the fundus or body. EG-REFS severity was significantly correlated with active histology, defined by a threshold of ≥30 eosinophils/high-power field ( P = 0.0002). DISCUSSION: Prospective application of EG-REFS identified gastric features with a strong correlation with physician global assessment of endoscopic activity in EG. Endoscopic features demonstrated greater severity in patients with active histology and a predilection for the gastric antrum. Further development of EG-REFS should improve its utility in clinical studies.
Humidified rapid‐insufflation ventilatory exchange is a means of oxygenation during rigid bronchoscopy: A case series
Kornafeld, Anna , Fernández-Bussy, Sebastián , García, Juan Cruz López, Garcia, Juan C, Abia‐Trujillo, David , Chadha, Ryan

Mayo Clinic

Respirology Case Reports | January 26, 2022 | Volume: 10 | Issue: 2 | Pages: No page available

10.1002/rcr2.903 | PMID 35111327 Get It

AbstractHumidified rapid‐insufflation ventilatory exchange (HRIVE) is an option for maintenance of oxygenation. This technique allows for oxygenation while the patient is apnoeic due to continuous positive airway pressure and gas exchange through flow‐dependent dead space flushing. There is no study about the usage of HRIVE during rigid bronchoscopy. This retrospective study looked at rigid bronchoscopy cases utilizing HRIVE. Data points assessing adequacy of oxygenation and ventilation were recorded at time points: oxygen saturation (SpO2), partial pressure of oxygen (PaO2) and partial pressure of carbon dioxide (PaCO2). Our nine cases had an average baseline SpO2 of 99.26%, 95.56% at 10 min into HRIVE and 95.27% at the end of HRIVE. The average baseline PaO2 was 309.01 mmHg, 124.99 mmHg at 10 min into HRIVE and 128.17 mmHg at the end of HRIVE. The average baseline PaCO2 was 43.26 mmHg, 68.76 mmHg at 10 min into HRIVE and 75.52 mmHg at the end of HRIVE. The average pre‐HRIVE end‐tidal CO2 (ETCO2) was 38.56 mmHg and the average post‐HRIVE ETCO2 was 61.22 mmHg. The average baseline pH was 7.36, 7.22 at 10 min into HRIVE and 7.19 at the end of HRIVE. In this small cohort study, HRIVE was able to maintain adequate oxygenation via the rigid bronchoscope in a select group of patients. Hypercapnia and respiratory acidosis did result after 10 min, which may predispose certain patient populations to complications. HRIVE potentially offers an additional option of oxygenation via the rigid bronchoscope.
Histologic acute graft pyelonephritis after kidney transplantation: Incidence, clinical characteristics, risk factors, and association with graft loss
Powers, H. R. , Hellinger, Walter C. , Cortese, Cherise , Elrefaei, Mohamed , Khouzam, Samir , Spiegel, Matthew R. , Li, Zhuo , Wadei, Hani M. , Powers, Harry R , Spiegel, Matthew, Wadei, Hani M

Mayo Clinic

Transplant Infectious Disease | January 26, 2022 | Volume: 24 | Issue: 2 | Pages: No page available

10.1111/tid.13801 | PMID 35080081 Get It

AbstractBackgroundHistologic acute graft pyelonephritis (HAGPN) after kidney transplantation (KT) has been assessed less frequently than urinary tract infections (UTIs) or clinical acute graft pyelonephritis. Risk factors for HAGPN, its association with graft loss, and measures that might prevent it are not known.MethodsWe performed a retrospective review of HAGPN cases identified from KT occurring between January 2008 and December 2017 at our institution. We compared the HAGPN cases to a randomly selected control group of KTs to identify risk factors using univariate and multivariate Cox regression models. The association between HAGPN and graft loss was also assessed, similarly.ResultsHAGPN was identified in 46 of 1391 patients (cumulative incidence, 5% [95% CI, 3%–7%]) undergoing KT at a single center from January 2008 through December 2017 (median time to diagnosis, 241 days after KT; interquartile range, 122–755 days). Indications for biopsy were follow‐up of treated rejection (n = 20 [43%]), KT protocol biopsy (n = 19 [41%]), and acute kidney injury (n = 7 [15%]). Histologic rejection, UTI, and asymptomatic bacteriuria (ASB) were present in 23 (50%), 9 (20%), and 16 (35%). Multivariate Cox proportional hazards models comparing KT recipients with or without HAGPN (n = 46 and n = 138, respectively) showed that HAGPN was associated with urologic complication by day 30, delayed graft function, previous UTI or ASB, and a history of rejection. In the univariate and multivariate analyses, HAGPN was associated with an increased risk of graft loss.ConclusionHAGPN is an infrequent, unanticipated, and clinically significant complication of KT.
Clinical Impact Requires Clinical Practice Research
Utianski, Rene L. , Spencer, Trina D. , Utianski, Rene L , Wallace, Sarah E.

Mayo Clinic

Perspectives of the ASHA Special Interest Groups | January 25, 2022 | Volume: 7 | Issue: 3 | Pages: 651-662

10.1044/2021_persp-21-00197 Get It

Purpose: The extent to which research impacts clinical practice is directly related to the availability, accessibility, and relevance of clinical practice research (CPR). The purpose of this article is to describe some of the current barriers to CPR in communication sciences and disorders and review the resources available to support clinical practice researchers. Results: Considerations related to CPR are numerous and relate to its availability, relevance, and accessibility. There are longstanding challenges with the CPR pipeline, which include challenges getting researchers involved in conducting CPR, acquisition of funding to support CPR grant proposals, recognition of the validity and role of less traditional research paradigms in which some CPR is conducted, and publishing and disseminating CPR. The American Speech-Language-Hearing Association (ASHA) has developed a number of resources to support the development, execution, dissemination, and utilization of CPR in speech-language pathology and audiology. Conclusions: Clinicians, researchers, and clinician-scientists alike are encouraged to explore ASHA's CPR resources and initiatives. The outcomes of ASHA programs are encouraging in that researchers who participate in CPR initiatives are largely successful in obtaining funding for CPR. This is promising evidence that the availability, relevance, and accessibility barriers to CPR can be mitigated, which will ultimately lead to improved uptake and impact of CPR.
Diagnosing Vitreoretinal Lymphomas—An Analysis of the Sensitivity of Existing Tools
Sehgal, Anahita, Pulido, José S. , Mashayekhi, Arman , Milman, Tatyana , Deák, Gábor , Deák, Gabor Gy

Mayo Clinic

Cancers | January 25, 2022 | Volume: 14 | Issue: 3 | Pages: 598

10.3390/cancers14030598 | PMID 35158867 Get It

Vitreoretinal lymphoma (VRL) is a rare ocular pathology that is notorious for mimicking chronic uveitis, which is a seemingly benign condition in comparison. The most common form of VRL is the diffuse large B-cell type, and there has been a high mortality rate. This dismal prognosis can be improved significantly if the disease is diagnosed early, but until now there is no consensus on an appropriate diagnostic algorithm. We conducted a retrospective search of PubMed Central® and analyzed results from thirty-three studies that were published between 2011–2021. The chosen studies incorporated some popular testing tools for VRL, and our analyses focused on comparing the average sensitivity of five diagnostic methods. The methods included cytology including ancillary immunohistochemistry, Myeloid Differentiation Factor 88 (MyD88) mutation analysis, polymerase chain reaction (PCR) for monoclonal rearrangements of immunoglobulin heavy chain (IgH) and T-cell Receptor (TCR) genes, flow cytometry, and IL10 and IL6 analysis. Across the varied diagnostic methods employed in thirty-three studies explored in this analysis, MyD88 mutation assay emerged as a strong contender given its sensitivity and low coefficient of variation. There is an imminent need for the introduction of newer assays that can further improve the sensitivity of identifying MyD88 mutation in cancer cells seen in the vitreous.